IDSA: MVA-BN Vaccine Against Mpox Tolerated, Effective for Teens

THURSDAY, Oct. 17, 2024-- The Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine, licensed in the United States to prevent smallpox and mpox, is well tolerated and seems effective in adolescents, according to a study presented at the annual...